Molecular Characterization of Achromobacter Isolates from Cystic Fibrosis and Non-Cystic Fibrosis Patients in Madrid, Spain-Reference-Cited by-同舟云学术

Molecular Characterization of Achromobacter Isolates from Cystic Fibrosis and Non-Cystic Fibrosis Patients in Madrid, Spain

Published:2013-06 Issue:6 Volume:51 Page:1927-1930
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Barrado Laura¹,Brañas Patricia¹,Orellana M. Ángeles¹,Martínez M. Teresa²,García Gloria²,Otero Joaquín R.¹,Chaves Fernando¹

Affiliation:

1. Servicio de Microbiología Clínica, Hospital Universitario 12 de Octubre, Madrid, Spain

2. Unidad de Fibrosis Quística, Hospital Universitario 12 de Octubre, Madrid, Spain

Abstract

ABSTRACT Multilocus sequence typing and nrdA sequence analysis identified 6 different species or genogroups and 13 sequence types (STs) among 15 Achromobacter isolates from cystic fibrosis (CF) patients and 7 species or genogroups and 11 STs among 11 isolates from non-CF patients. Achromobacter xylosoxidans was the most frequently isolated species among CF patients.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00494-13

Reference21 articles.

1. The Changing Microbial Epidemiology in Cystic Fibrosis

2. A Multilocus Sequence Typing Scheme Implies Population Structure and Reveals Several Putative Novel Achromobacter Species

3. Identification and distribution of Achromobacter species in cystic fibrosis

4. Achromobacter animicus sp. nov., Achromobacter mucicolens sp. nov., Achromobacter pulmonis sp. nov. and Achromobacter spiritinus sp. nov., from human clinical samples

5. Multilocus Sequence Analysis of Isolates of Achromobacter from Patients with Cystic Fibrosis Reveals Infecting Species Other than Achromobacter xylosoxidans

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains;Annals of Clinical Microbiology and Antimicrobials;2024-06-17

2. In Vitro Susceptibility of Achromobacter Species Isolated from Cystic Fibrosis Patients: a 6-Year Survey;Antimicrobial Agents and Chemotherapy;2023-07-18

3. Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis;Journal of Cystic Fibrosis;2023-03

4. Achromobacter spp. prevalence and adaptation in cystic fibrosis lung infection;Microbiological Research;2022-10

5. Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis;Frontiers in Cellular and Infection Microbiology;2022-06-16